Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites.
Muijlwijk T, Nijenhuis DNLM, Ganzevles SH, Brink A, Ke C, Fass JN, Rajamanickam V, Leemans CR, Koguchi Y, Fox BA, Poell JB, Brakenhoff RH, van de Ven R. Muijlwijk T, et al. Among authors: van de ven r. J Immunother Cancer. 2024 Jan 11;12(1):e007573. doi: 10.1136/jitc-2023-007573. J Immunother Cancer. 2024. PMID: 38212122 Free PMC article.
NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models.
Gruijs M, Ganzevles SH, Stigter-van Walsum M, van der Mast R, van Ostaijen-Ten Dam MM, Tuk CW, Schilham MW, Leemans CR, Brakenhoff RH, van Egmond M, van de Ven R, Bakema JE. Gruijs M, et al. Among authors: van der mast r, van de ven r, van ostaijen ten dam mm, van egmond m. Int J Mol Sci. 2021 Oct 14;22(20):11057. doi: 10.3390/ijms222011057. Int J Mol Sci. 2021. PMID: 34681717 Free PMC article.
An Antibody-Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy.
Bakema JE, Stigter-van Walsum M, Harris JR, Ganzevles SH, Muthuswamy A, Houtkamp M, Plantinga TS, Bloemena E, Brakenhoff RH, Breij ECW, van de Ven R. Bakema JE, et al. Among authors: van de ven r. Mol Cancer Ther. 2024 Feb 1;23(2):187-198. doi: 10.1158/1535-7163.MCT-23-0298. Mol Cancer Ther. 2024. PMID: 37828725
Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy.
van Duijvenvoorde M, Derks S, Bahce I, Leemans CR, van de Ven R, Fransen MF. van Duijvenvoorde M, et al. Among authors: van de ven r. Clin Transl Immunology. 2022 Jan 10;11(1):e1363. doi: 10.1002/cti2.1363. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35035956 Free PMC article. Review.
Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway.
van Pul KM, Vuylsteke RJCLM, de Beijer MTA, van de Ven R, van den Tol MP, Stockmann HBAC, de Gruijl TD. van Pul KM, et al. Among authors: de beijer mta, van de ven r, van den tol mp, de gruijl td. J Immunother Cancer. 2020 Oct;8(2):e000761. doi: 10.1136/jitc-2020-000761. J Immunother Cancer. 2020. PMID: 33046620 Free PMC article.
Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma.
Baird JR, Bell RB, Troesch V, Friedman D, Bambina S, Kramer G, Blair TC, Medler T, Wu Y, Sun Z, de Gruijl TD, van de Ven R, Leidner RS, Crittenden MR, Gough MJ. Baird JR, et al. Among authors: van de ven r, de gruijl td. Cancer Res. 2018 Nov 1;78(21):6308-6319. doi: 10.1158/0008-5472.CAN-18-1652. Epub 2018 Sep 17. Cancer Res. 2018. PMID: 30224374
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node.
van Pul KM, Vuylsteke RJCLM, van de Ven R, Te Velde EA, Rutgers EJT, van den Tol PM, Stockmann HBAC, de Gruijl TD. van Pul KM, et al. Among authors: van de ven r, van den tol pm, de gruijl td. J Immunother Cancer. 2019 May 22;7(1):133. doi: 10.1186/s40425-019-0605-1. J Immunother Cancer. 2019. PMID: 31118093 Free PMC article.
143 results